Carleen Klumpp‐Thomas

机构：National Institutes of Health, Innovative Clinical Research, National Center for Advancing Translational Sciences · ORCID：0000-0002-6646-6132

发表论文 270 篇 · 总被引 3162 次 · h-index 28

代表论文

• Elucidating molecularly stratified single agent, and combination, therapeutic strategies targeting MCL1 for lethal prostate cancer (2025 · Nature Communications · 被引 6)
• An Assessment of Kinase Selectivity, Enzyme Inhibition Kinetics and in Vitro Activity for Several Bruton Tyrosine Kinase (BTK) Inhibitors (2025 · ACS Pharmacology & Translational Science · 被引 3)
• Integrating qHTS and QSAR Models to Identify Safe GPCR-Targeted Compounds: A Focus on hERG-Dependent Cardiotoxicity (2026 · Journal of Chemical Information and Modeling · 被引 1)
• Systematic evaluation of Tox21 compounds that target β-adrenergic receptors and their role in cardiotoxicity (2025 · Toxicology and Applied Pharmacology · 被引 1)
• Therapeutic NAMPT inhibition reveals a targetable metabolic vulnerability in neuroblastoma (2026 · Journal of Experimental & Clinical Cancer Research)
• Supplementary Figure 1 from CellMinerCDB: NCATS Is a Web-Based Portal Integrating Public Cancer Cell Line Databases for Pharmacogenomic Explorations (2025)